Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 4, 2012, Pages 385-392

  Bi, Sheng Hui ^a,c   Jin, Zhen Xiao ^a,c   Zhang, Jian Ying ^a,c   Chen, Tao ^a   Zhang, Sheng Li ^a   Yang, Yang ^a   Duan, Wei Xun ^a   Yi, Ding Hua ^a   Zhou, Jing Jun ^a,b   Ren, Jun ^b,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Calcium; Calcium overload; Calcium paradox; Calpain

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; ALPHA FODRIN; CALCIUM; CALPAIN; CYTOCHROME C; FODRIN; LACTATE DEHYDROGENASE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM DEPLETION; CALCIUM PARADOX; CELL DEATH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE INJURY; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PERFUSION; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT;

ANIMALS; CALCIUM; CALPAIN; CARDIOTONIC AGENTS; CELL DEATH; DIPEPTIDES; GLYCOPROTEINS; MALE; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84858975216     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05683.x     Document Type: Article

References (37)

1. Zimmerman AN, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 1966; 211: 646-7.
2. Piper HM. The calcium paradox revisited: An artefact of great heuristic value. Cardiovasc. Res. 2000; 45: 123-7.
3. Grinwald PM, Nayler WG. Calcium entry in the calcium paradox. J. Mol. Cell. Cardiol. 1981; 13: 867-80.
4. 2+ paradox injury mediated through TRPC channels in mouse ventricular myocytes. Br. J. Pharmacol. 2010; 161: 1734-50.
5. Daly MJ, Elz JS, Nayler WG. Contracture and the calcium paradox in the rat heart. Circ. Res. 1987; 61: 560-9.
6. Ganote CE, Nayler WG. Contracture and the calcium paradox. J. Mol. Cell. Cardiol. 1985; 17: 733-45.
7. Xu YJ, Saini HK, Zhang M, Elimban V, Dhalla NS. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc. Res. 2006; 72: 163-74.
8. 2+ repletion. Can. J. Physiol. Pharmacol. 2009; 87: 789-97.
9. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol. Rev. 2003; 83: 731-801.
10. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004; 53(Suppl. 1): S12-18.
11. Chang H, Zhang L, Xu PT et al. Nuclear translocation of calpain-2 regulates propensity toward apoptosis in cardiomyocytes of tail-suspended rats. J. Cell. Biochem. 2011; 112: 571-80.
12. Hernando V, Inserte J, Sartorio CL, Parra VM, Poncelas-Nozal M, Garcia-Dorado D. Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion. J. Mol. Cell. Cardiol. 2010; 49: 271-9.
13. +-ATPase are due to the activation of calpain in the heart. Can. J. Physiol. Pharmacol. 2010; 88: 388-97.
14. Sandmann S, Prenzel F, Shaw L, Schauer R, Unger T. Activity profile of calpains I and II in chronically infarcted rat myocardium: Influence of the calpain inhibitor CAL 9961. Br. J. Pharmacol. 2002; 135: 1951-8.
15. Galvez AS, Diwan A, Odley AM et al. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ. Res. 2007; 100: 1071-8.
16. Mani SK, Balasubramanian S, Zavadzkas JA et al. Calpain inhibition preserves myocardial structure and function following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H1744-51.
17. Li Y, Feng Q, Arnold M, Peng T. Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc. Res. 2009; 84: 100-10.
18. Larsen TH, Dalen H, Sommer JR, Boyle R, Lieberman M. Membrane skeleton in cultured chick cardiac myocytes revealed by high resolution immunocytochemistry. Histochem. Cell Biol. 1999; 112: 307-16.
19. Bennett V, Baines AJ. Spectrin and ankyrin-based pathways: Metazoan inventions for integrating cells into tissues. Physiol. Rev. 2001; 81: 1353-92.
20. Armstrong SC, Latham CA, Shivell CL, Ganote CE. Ischemic loss of sarcolemmal dystrophin and spectrin: Correlation with myocardial injury. J. Mol. Cell. Cardiol. 2001; 33: 1165-79.
21. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Agullo L, Pina P, Soler-Soler J. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc. Res. 2004; 64: 105-14.
22. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 2001; 276: 30724-8.
23. Yoshida K, Inui M, Harada K et al. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain. Circ. Res. 1995; 77: 603-10.
24. Chohan PK, Singh RB, Dhalla NS, Netticadan T. l-Arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc. Res. 2006; 69: 152-63.
25. Gaitanaki C, Papazafiri P, Beis I. The calpain-calpastatin system and the calcium paradox in the isolated perfused pigeon heart. Cell. Physiol. Biochem. 2003; 13: 173-80.
26. Urthaler F, Wolkowicz PE, Digerness SB, Harris KD, Walker AA. MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc. Res. 1997; 35: 60-7.
27. +-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ. Res. 2005; 97: 465-73.
28. Donkor IO. A survey of calpain inhibitors. Curr. Med. Chem. 2000; 7: 1171-88.
29. Shan L, Li J, Wei M et al. Disruption of Rac1 signaling reduces ischemia-reperfusion injury in the diabetic heart by inhibiting calpain. Free Radic. Biol. Med. 2010; 49: 1804-14.
30. +-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes. J. Mol. Cell. Cardiol. 2010; 49: 459-68.
31. Kim HS, Cho JE, Hwang KC, Shim YH, Lee JH, Kwak YL. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Eur. J. Pharmacol. 2010; 628: 132-9.
32. Xing W, Yan W, Fu F et al. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function. Apoptosis 2009; 14: 1050-60.
33. Vahasilta T, Malmberg M, Saraste A et al. Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia during aortic valve surgery. Ann. Thorac. Surg. 2011; 92: 1351-7.
34. Khalil PN, Neuhof C, Huss R et al. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. Eur. J. Pharmacol. 2005; 528: 124-31.
35. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 1999; 79: 609-34.
36. Willis MS, Schisler JC, Portbury AL, Patterson C. Build it up-tear it down: Protein quality control in the cardiac sarcomere. Cardiovasc. Res. 2009; 81: 439-48.
37. Maekawa A, Lee JK, Nagaya T et al. Overexpression of calpastatin by gene transfer prevents troponin I degradation and ameliorates contractile dysfunction in rat hearts subjected to ischemia/reperfusion. J. Mol. Cell. Cardiol. 2003; 35: 1277-84.